This site uses cookies to store information on your computer. Learn more x

Consensus Figures

A number of international financial analysts cover DSM. The most recent consensus figures – provided by Vara Research – are detailed below. The figures are based on the estimates given by the banks that were approached by Vara Research.

Analysts' consensus Q4 2017, FY 2017 and FY 2018 published 12 January 2018

  Q4 2016 FY 2016 Q4 2017 E FY 2017 E FY 2018 E
Sales (continuing)          
Number of Estimates     19 19 19
Highest     2,191 8,647 9,040
Consensus 2,015 7,920 2,079 8,535 8,854
Median     2,074 8,530 8,851
Lowest     1,975 8,431 8,644
Adj. EBITDA (continuing)          
Number of Estimates     19 19 19
Highest     379 1,465 1,677
Consensus 315 1,262 340 1,426 1,558
Median     339 1,425 1,547
Lowest     314 1,400 1,492
Adj. EBIT (continuing)          
Number of Estimates     18 19 19
Highest     254 971 1,165
Consensus 190 791 219 936 1,062
Median     217 935 1,045
Lowest     195 912 1,010
Nutrition, Sales          
Number of Estimates     17 17 17
Highest     1,454 5,605 5,919
Consensus 1,321 5,169 1,352 5,503 5,716
Median     1,346 5,497 5,712
Lowest     1,292 5,443 5,549
Nutrition, adj. EBITDA          
Number of Estimates     17 17 17
Highest     290 1,076 1,272
Consensus 238 931 254 1,041 1,155
Median     253 1,039 1,142
Lowest     237 1,023 1,100
Nutrition, adj. EBIT          
Number of Estimates     16 16 16
Highest     216 791 953
Consensus 160 645 180 755 861
Median     179 754 847
Lowest     165 740 809
Materials, Sales          
Number of Estimates     17 17 17
Highest     704 2,836 2,971
Consensus 639 2,513 672 2,804 2,890
Median     671 2,803 2,903
Lowest     642 2,774 2,763
Materials, adj. EBITDA          
Number of Estimates     17 17 17
Highest     117 486 526
Consensus 105 435 111 480 495
Median     111 480 493
Lowest     102 471 462
Materials, adj. EBIT          
Number of Estimates     16 16 16
Highest     88 363 390
Consensus 77 311 80 355 365
Median     79 354 365
Lowest     70 345 335
Innovation Center, Sales          
Number of Estimates     16 16 16
Highest     49 175 193
Consensus 41 167 44 170 177
Median     43 169 177
Lowest     41 167 168
Innovation Center, adj. EBITDA          
Number of Estimates     16 16 16
Highest     4 9 16
Consensus -1 1 1 6 9
Median     1 6 10
Lowest     -1 4 0
Innovation Center, adj. EBIT          
Number of Estimates     15 15 15
Highest     10 -19 -9
Consensus -9 -24 -4 -33 -20
Median     -6 -35 -18
Lowest     -20 -49 -39
Corporate Activities, Sales          
Number of Estimates     16 16 16
Highest     26 73 88
Consensus 14 71 18 65 68
Median     16 63 66
Lowest     13 60 60
Corporate Activities, adj. EBITDA          
Number of Estimates     16 16 16
Highest     -22 -96 -88
Consensus -27 -105 -25 -99 -100
Median     -25 -99 -100
Lowest     -29 -103 -110
Corporate Activities, adj. EBIT          
Number of Estimates     15 15 15
Highest     -29 -133 -128
Consensus -38 -141 -35 -139 -139
Median     -35 -139 -139
Lowest     -42 -146 -151
adj. Net Profit for the period, before exceptional items - Cont. Ops.          
Number of Estimates     17 17 17
Highest     226.0 729.6 890.8
Consensus 130.0 508.0 164.1 666.1 788.4
Median     155.6 658.0 782.0
Lowest     139.0 643.0 735.1
adj. Net EPS before exceptional items - Cont. Ops.          
Number of Estimates     17 17 17
Highest     1.28 4.13 5.00
Consensus 0.73 2.89 0.93 3.75 4.44
Median     0.90 3.72 4.36
Lowest     0.80 3.62 4.10

DSM Disclaimer

Consensus earnings estimates are based on earnings projections made by securities analysts who cover DSM. Any opinions, forecasts, estimates, projections or predictions regarding DSM’s performance made by the analysts (and, therefore, the Consensus estimate numbers) are theirs alone and do not represent the opinions, forecasts, estimates, projections or predictions of DSM or its management. DSM does not by providing these estimates imply its endorsement of or concurrence with such information, conclusions or recommendations. DSM assumes no liability for the accuracy of such estimates and undertakes no obligation to update or revise such estimates.